question_key
stringlengths 16
58
| relation
stringlengths 6
48
| question_template
stringlengths 29
90
| subject_cui
stringlengths 8
8
| subject_label
stringlengths 4
160
| correct_object_cui
stringlengths 8
8
| correct_object_label
stringlengths 3
204
| opa
stringlengths 7
150
| opb
stringlengths 3
204
| opc
stringlengths 4
221
| opd
stringlengths 5
166
| cop
int64 0
3
|
---|---|---|---|---|---|---|---|---|---|---|---|
C1515261::has_gene_product_element | has_gene_product_element | Which gene product is an element of the pathway {subj}? | C1515261 | Telomere Pathway | C1333229 | POLR2A protein, human | SAR1B protein, human | POLR2A protein, human | PRRT2 protein, human | RSAD2 protein, human | 1 |
C2265640::has_gene_product_element | has_gene_product_element | Which gene product is an element of the pathway {subj}? | C2265640 | Autophagy Regulation Pathway | C0967698 | RRAGC protein, human | RETN protein, human | DNER protein, human | NRBP protein, human | RRAGC protein, human | 3 |
C1877749::has_ingredient | has_ingredient | Which of the following is an ingredient of {subj}? | C1877749 | {21 (ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack | C0068992 | norgestimate | Norgestomet only product | norgestimate | norgestrel and estrogen | Norgestimate only product | 1 |
C2955132::has_ingredient | has_ingredient | Which of the following is an ingredient of {subj}? | C2955132 | Duet DHA Balanced, Prenatal Multivitamins with Folic Acid 1 mg oral kit | C0008318 | cholecalciferol | cholecalciferol / glucosamine | cholecalciferol / chromium picolinate | cholecalciferol | cholecalciferol / levomefolate | 2 |
C1962428::has_ingredient | has_ingredient | Which of the following is an ingredient of {subj}? | C1962428 | {21 (ethinyl estradiol 0.05 MG / ethynodiol diacetate 1 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Zovia 1/50E 28 Day] | C0015011 | ethinyl estradiol | chlormadinone / ethinyl estradiol | ethinyl estradiol | chlormadinone and ethinylestradiol | algestone / estradiol | 1 |
C5852768::has_inherent_location | has_inherent_location | What is the inherent location of {subj}? | C5852768 | Laterality of primary malignant neoplasm of oral soft tissue | C0447424 | Oral soft tissues | Orbital Ridge | Oral soft tissues | Hard tissue of tooth | Structure of soft tissues of buttock | 1 |
C5852686::has_inherent_location | has_inherent_location | What is the inherent location of {subj}? | C5852686 | Histologic grade of primary malignant neoplasm of cecum and/or colon and/or rectum | C5848823 | Structure of cecum and/or colon and/or rectum | Structure of pelvic aspect of sacrum | Structure of cecum and/or colon and/or rectum | Structure of mesenteric border of jejunum | Structure of posterior margin of nasal septum and/or choana | 1 |
C5852596::has_inherent_location | has_inherent_location | What is the inherent location of {subj}? | C5852596 | Surgical margin closest to noninvasive premalignant neoplasm in excised pharynx specimen | C0031354 | Pharyngeal structure | Hyponychium of ring finger | Pharyngeal hypophysis | Pharyngeal structure | Stapedial membrane | 2 |
C1843355::has_inheritance_type | has_inheritance_type | What is the inheritance type of {subj}? | C1843355 | ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS | C0441748 | Autosomal recessive inheritance | somatic recombination of T cell receptor gene segments | Genetic independent segregation | Autosomal recessive inheritance | Allelic exclusion | 2 |
C5779972::has_inheritance_type | has_inheritance_type | What is the inheritance type of {subj}? | C5779972 | LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER 1 | C0441748 | Autosomal recessive inheritance | Autosomal recessive inheritance | meiotic DNA recombinase assembly involved in meiotic gene conversion | Genetic independent segregation | Recombination, Genetic | 0 |
C5830291::has_inheritance_type | has_inheritance_type | What is the inheritance type of {subj}? | C5830291 | CARDIOMYOPATHY, DILATED, 1OO | C0443147 | Autosomal dominant inheritance | Autosomal dominant inheritance | Nondisjunction, Genetic | Allelic exclusion | Recombination, Genetic | 0 |
C2091838::has_intent | has_intent | What is the intent of {subj}? | C2091838 | Prophylactic pinning of femoral neck and proximal femur | C0199176 | Prophylactic treatment | Prophylactic treatment | Prophylactic wrist stretching | Prophylactic knee stretching | Prophylactic hip stretching | 0 |
C2945703::has_intent | has_intent | What is the intent of {subj}? | C2945703 | Prophylactic oophorectomy | C0199176 | Prophylactic treatment | Prophylaxis of abortion | Prophylactic treatment | Administration of prophylactic treatment | Prophylactic wrist stretching | 1 |
C2191320::has_intent | has_intent | What is the intent of {subj}? | C2191320 | Prophylactic Mastectomy | C0199176 | Prophylactic treatment | Prophylactic ankle stretching | Prophylactic shoulder stretching | Prophylactic treatment | Administration of prophylactic treatment | 2 |
C1183575::has_lymphatic_drainage | has_lymphatic_drainage | What is the lymphatic drainage of {subj}? | C1183575 | Superficial fascia of right breast proper | C2328170 | Cutaneous lymphatic tree of right breast proper | Structure of lymphatic vessel of right foot | Structure of lymphatic vessel of right axilla | Cutaneous lymphatic tree of right breast proper | Trunk of right lower lobe lymphatic tree | 2 |
C0230329::has_lymphatic_drainage | has_lymphatic_drainage | What is the lymphatic drainage of {subj}? | C0230329 | Right upper extremity | C0933321 | Right subclavian lymphatic tree | Left lower intercostal lymphatic vessel | Right apical axillary lymphatic vessel | Right jugular lymphatic tree | Right subclavian lymphatic tree | 3 |
C0929543::has_lymphatic_drainage | has_lymphatic_drainage | What is the lymphatic drainage of {subj}? | C0929543 | Central area of central tendon | C2328358 | Lateral diaphragmatic lymphatic chain | Lymphatic chain of lateral segmental bronchus | Right lower intercostal lymphatic vessel | Entire lateral pericardial lymph node | Lateral diaphragmatic lymphatic chain | 3 |
C4749028::has_manifestation | has_manifestation | What is a manifestation of {subj}? | C4749028 | CILIARY DYSKINESIA, PRIMARY, 40 | C0035455 | Rhinitis | Obstructive rhinitis | Other allergic rhinitis | Rhinitis | Ulcerative rhinitis | 2 |
C5774243::has_manifestation | has_manifestation | What is a manifestation of {subj}? | C5774243 | CLEIDOCRANIAL DYSPLASIA 2 | C0018784 | Sensorineural Hearing Loss (disorder) | Sudden sensorineural hearing loss | Sensorineural Hearing Loss (disorder) | Congenital mixed conductive and sensorineural hearing loss | Maternal perinatal sensorineural hearing loss | 1 |
C2751535::has_manifestation | has_manifestation | What is a manifestation of {subj}? | C2751535 | Prostaglandin-Endoperoxide Synthase 1 Deficiency, Platelet | C0025323 | Menorrhagia | Hemorrhagic vaginal discharge | Premenopausal menorrhagia | Menorrhagia | Hemorrhagic inflammation | 2 |
C0770891::has_mechanism_of_action | has_mechanism_of_action | What is the mechanism of action of {subj}? | C0770891 | flupentixol hydrochloride | C2757008 | Dopamine Antagonists [MoA] | Decreased Serotonin Degradation | negative regulation of L-dopa decarboxylase activity | Dopamine Antagonists [MoA] | tryptamine 4-monooxygenase activity | 2 |
C0060501::has_mechanism_of_action | has_mechanism_of_action | What is the mechanism of action of {subj}? | C0060501 | flunisolide | C1373068 | Glucocorticoid Receptor Agonists | Cytokine Receptor Activation | Pituitary Hormone Receptor Binding | Glucocorticoid Receptor Agonists | glucocorticoid biosynthetic process | 2 |
C0031978::has_mechanism_of_action | has_mechanism_of_action | What is the mechanism of action of {subj}? | C0031978 | pirenzepine | C1373102 | Cholinergic Muscarinic Antagonists [MoA] | Increased Acetylcholine Activity | Increased Sensory-Somatic Nervous System Substance P Activity | Cholinergic Muscarinic Antagonists [MoA] | Serotonin Receptor Binding | 2 |
C0927199::has_member | has_member | Which of the following is a member of {subj}? | C0927199 | Musculature of mouth | C0921226 | Left levator anguli oris | Left levator anguli oris | Third levator costae muscle | Left torus levatorius | Nerve to left depressor anguli oris | 0 |
C2335931::has_member | has_member | Which of the following is a member of {subj}? | C2335931 | Lymph node group of left axilla | C2328374 | Left pectoral lymph node | Entire pectoral axillary lymph node | Left pectoral lymph node | Left pectoral axillary lymphatic chain | Superior mediastinal lymph node | 1 |
C0833291::has_member | has_member | Which of the following is a member of {subj}? | C0833291 | Set of thenar muscles | C0224288 | Adductor pollicis muscle structure | Structure of right abductor pollicis longus tendon sheath | Entire extensor pollicis longus muscle tendon sheath | Adductor pollicis muscle structure | Head of adductor pollicis muscle | 2 |
C0025853::has_modification | has_modification | What modification does {subj} have? | C0025853 | metoclopramide | C0887128 | metoclopramide hydrochloride | metoclopramide hydrochloride | ractopamine hydrochloride | trifluperidol hydrochloride | bupranolol hydrochloride | 0 |
C0053225::has_modification | has_modification | What modification does {subj} have? | C0053225 | benzoic acid | C0142805 | sodium benzoate | sodium benzoate | sodium propionate | benzocaine / zinc oxide | sodium succinate | 0 |
C0022060::has_modification | has_modification | What modification does {subj} have? | C0022060 | Ipronidazole | C0521905 | Ipronidazole hydrochloride | levomilnacipran hydrochloride | benactyzine hydrochloride + meprobamate | Ipronidazole hydrochloride | phendimetrazine hydrochloride | 2 |
C0038351::has_nerve_supply | has_nerve_supply | What is the nerve supply of {subj}? | C0038351 | Stomach | C2330104 | Left phrenic nerve plexus | Left second superior phrenic artery | Left phrenic nerve plexus | Right inferior phrenic artery | Diaphragmatic branch of left phrenic nerve | 1 |
C0224384::has_nerve_supply | has_nerve_supply | What is the nerve supply of {subj}? | C0224384 | Structure of levator ani muscle | C0228960 | Structure of hemorrhoidal nerve | Structure of hyaloid artery | Entire hemorrhoidal nerve | Structure of genicular artery | Structure of hemorrhoidal nerve | 3 |
C0224349::has_nerve_supply | has_nerve_supply | What is the nerve supply of {subj}? | C0224349 | Structure of serratus anterior muscle | C0228847 | Structure of long thoracic nerve | Trunk of thoracic nerve | Structure of internal thoracic vein | Structure of long thoracic nerve | Structure of superior thoracic artery | 2 |
C1325550::has_occurrence | has_occurrence | When does {subj} typically occur? | C1325550 | chromatin location | C3158202 | DNA-binding transcription factor activity, RNA polymerase II-specific | transcription antitermination factor activity, DNA binding | RNA polymerase III general transcription initiation factor activity | DNA-binding transcription factor activity, RNA polymerase II-specific | transcription antitermination factor activity, RNA binding | 2 |
C0230789::has_occurrence | has_occurrence | When does {subj} typically occur? | C0230789 | Smooth Endoplasmic Reticulum | C1656576 | smooth endoplasmic reticulum calcium ion homeostasis | endoplasmic reticulum organization | regulation of translation in response to endoplasmic reticulum stress | endoplasmic reticulum tubular network organization | smooth endoplasmic reticulum calcium ion homeostasis | 3 |
C0039062::has_occurrence | has_occurrence | When does {subj} typically occur? | C0039062 | Synapses | C4236598 | regulation of translation at synapse, modulating synaptic transmission | negative regulation of postsynaptic membrane organization | positive regulation of synapse assembly | positive regulation of synaptic vesicle membrane organization | regulation of translation at synapse, modulating synaptic transmission | 3 |
C0734003::has_part | has_part | Which of the following is a part of {subj}? | C0734003 | Wall of ileum | C0227317 | Ileal mucous membrane | Ileal mucous membrane | Structure of left buccal mucosa | Mucosa of ureter proper | Vesical fundus part of vaginal artery | 0 |
C3535926::has_part | has_part | Which of the following is a part of {subj}? | C3535926 | alogliptin / metformin | C1958126 | alogliptin | Digiglusin | ecallantide | alogliptin | soblidotin | 2 |
C1278910::has_part | has_part | Which of the following is a part of {subj}? | C1278910 | Entire oral cavity | C0447421 | Midline of hard palate | Structure of right nasal-orbit bony complex | Medial surface of left auricular cartilage | Midline of hard palate | Right side of nasopharynx | 2 |
C1290530::has_pathological_process | has_pathological_process | What pathological process is associated with {subj}? | C1290530 | Lateral accessory root canals | C0586102 | Pathological developmental process | Abnormal degeneration | Pathological fracture of ankle | Pathological developmental process | Chronic dilatation | 2 |
C5190891::has_pathological_process | has_pathological_process | What pathological process is associated with {subj}? | C5190891 | Hereditary isolated aplastic anemia | C4708780 | Abnormal immune process | Abnormal Virilization | Abnormal immune process | Abnormal granulocyte production | Abnormal bladder function | 1 |
C0015406::has_pathological_process | has_pathological_process | What pathological process is associated with {subj}? | C0015406 | Eye Infections, Parasitic | C0745283 | INFECTIOUS PROCESS | INFECTIOUS PROCESS | Hypothalamic dysfunction, NEC in SNOMEDCT | Neurogenic bowel, NEC in SNOMEDCT | Severe vaginal dysplasia, NEC in SNOMED CT | 0 |
C3865296::has_pathology | has_pathology | What pathology is associated with {subj}? | C3865296 | Quantitative carotid intima media thickness and carotid atheroma evaluation, bilateral | C0264956 | Atheroma | Osteolysis | Atheroma | Hyperthecosis | Thrombosis | 1 |
C2724268::has_pathology | has_pathology | What pathology is associated with {subj}? | C2724268 | Aortic root translocation with ventricular septal defect and pulmonary stenosis repair (ie, Nikaidoh procedure); without coronary ostium reimplantation | C1261287 | Stenosis | Venous stenosis | Stenosis of stoma | Secondary osteolysis | Stenosis | 3 |
C0371182::has_pathology | has_pathology | What pathology is associated with {subj}? | C0371182 | Repair, nonunion or malunion, femur, distal to head and neck; with iliac or other autogenous bone graft (includes obtaining graft) | C0158454 | Malunited Fracture | Pathological fracture, unspecified humerus, subsequent encounter for fracture with malunion | Malunited Fracture | Pathological fracture, unspecified ulna and radius, subsequent encounter for fracture with malunion | Bipartite ossification | 1 |
C0042849::has_permuted_term | has_permuted_term | What is a permuted term for {subj}? | C0042849 | vitamin B complex | C3714647 | Vitamin B Drug Class | Vitamin E Skin | Vitamin K5 only product | Vitaminoftalmina | Vitamin B Drug Class | 3 |
C4226417::has_phenotype | has_phenotype | What phenotype is associated with {subj}? | C4226417 | GFM2, IVS4DS, A-G, +4 | C5193075 | Combined oxidative phosphorylation defect type 39 | Glycogen phosphorylase kinase deficiency, X-linked | Deficiency of phosphoribokinase | Combined oxidative phosphorylation defect type 39 | Deficiency of phosphoglucomutase | 2 |
C4746671::has_phenotype | has_phenotype | What phenotype is associated with {subj}? | C4746671 | PMP2, ILE43ASN | C4748940 | CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1G | KERATODERMA, PALMOPLANTAR, PUNCTATE TYPE II | ENDOVE SYNDROME, LIMB-ONLY TYPE | CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1G | CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA | 2 |
C5542422::has_phenotype | has_phenotype | What phenotype is associated with {subj}? | C5542422 | SLCO2A1, IVS13, G-A, +1 | C3280800 | HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 2 | SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3 | HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 2 | GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES | CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 2 | 1 |
C0018826::has_physical_part_of_anatomic_structure | has_physical_part_of_anatomic_structure | Which physical part of an anatomic structure does {subj} have? | C0018826 | Heart Valves | C0225929 | Anterior leaflet of tricuspid valve | Entire septal leaflet of tricuspid valve | Leaflet of mitral valve | Lunule of anterior cusp of aortic valve | Anterior leaflet of tricuspid valve | 3 |
C0021853::has_physical_part_of_anatomic_structure | has_physical_part_of_anatomic_structure | Which physical part of an anatomic structure does {subj} have? | C0021853 | Intestines | C1519375 | Small Intestinal Wall Tissue | Large intestine or small intestine Tissue | Entire interstitial tissue of gastrointestinal tract | Tissue specimen from small intestine | Small Intestinal Wall Tissue | 3 |
C0796361::has_physical_part_of_anatomic_structure | has_physical_part_of_anatomic_structure | Which physical part of an anatomic structure does {subj} have? | C0796361 | Chromosome 7q | C1521643 | 7q21.2-q22.1 | 7q21.2-q22.1 | Chromosomes, Human, 4-5 | chromosome, centromeric region | polytene chromosome chromocenter | 0 |
C0033230::has_physiologic_effect | has_physiologic_effect | What physiologic effect does {subj} have? | C0033230 | prochlorperazine edisylate | C2267194 | Decreased Central Nervous System Norepinephrine Activity | Decreased Central Nervous System Norepinephrine Activity | Negative Regulation of Degradation of Complement | central nervous system control of baroreceptor feedback | Negative Regulation of Degradation of Antibody | 0 |
C0010137::has_physiologic_effect | has_physiologic_effect | What physiologic effect does {subj} have? | C0010137 | cortisone | C1371294 | Carbohydrate Metabolism Alteration [PE] | Carbohydrate Metabolism Alteration [PE] | trehalose transport in response to water deprivation | carbohydrate transmembrane transport | cell wall polysaccharide catabolic process | 0 |
C0530105::has_physiologic_effect | has_physiologic_effect | What physiologic effect does {subj} have? | C0530105 | cisatracurium besylate | C2917293 | Neuromuscular Nondepolarizing Blockade | establishment of synaptic specificity at neuromuscular junction | Neuromuscular Nondepolarizing Blockade | negative regulation of synaptic transmission, GABAergic | Cardiac Muscle Contraction | 1 |
C1170420::has_precise_ingredient | has_precise_ingredient | What precise ingredient does {subj} contain? | C1170420 | Natelle | C0556150 | docosahexaenoic acid | calcium carbonate / docosahexaenoate | cholecalciferol / docosahexaenoate / eicosapentaenoate / vitamin E | Docosahexaenoic acid and eicosapentaenoic acid only product | docosahexaenoic acid | 3 |
C0720260::has_precise_ingredient | has_precise_ingredient | What precise ingredient does {subj} contain? | C0720260 | Ergamisol | C0733383 | levamisole hydrochloride | budipine hydrochloride | levamisole hydrochloride | amosulalol hydrochloride | procaterol hydrochloride | 1 |
C0305104::has_precise_ingredient | has_precise_ingredient | What precise ingredient does {subj} contain? | C0305104 | AK-Con-A | C0887016 | pheniramine maleate | pheniramine aminosalicylate | triamterene / xipamide | pheniramine maleate | butaperazine maleate | 2 |
C2207747::has_procedure_site | has_procedure_site | What is the procedure site of {subj}? | C2207747 | microbiology test of right ear canal | C0579182 | Inner ear and/or Eustachian canal structures | Inner ear and/or Eustachian canal structures | Left vestibulocochlear artery | Cochlear nucleus structure | Entire mucous membrane of Eustachian tube | 0 |
C2010299::has_procedure_site | has_procedure_site | What is the procedure site of {subj}? | C2010299 | gait training on dirt or uneven terrain using prosthesis for right upper extremity | C0230329 | Right upper extremity | Lower extremity.right>Tibia | Left upper arm structure | Right upper extremity | Lower extremity.right>Femur | 2 |
C0370433::has_procedure_site | has_procedure_site | What is the procedure site of {subj}? | C0370433 | Excision, malignant lesion including margins, face, ears, eyelids, nose, lips; excised diameter over 4.0 cm | C0222110 | Skin structure of ear | Skin structure of left calf | Structure of skin of left thigh | Skin structure of left shoulder | Skin structure of ear | 3 |
C0448492::has_segmental_supply | has_segmental_supply | What is the segmental supply of {subj}? | C0448492 | First lumbrical muscle of foot | C1179704 | S1 innervation | S1 innervation | C3 branch to trapezius | Entire ventral lateral nucleus of thalamus | Pons and cerebellum, CS | 0 |
C0224268::has_segmental_supply | has_segmental_supply | What is the segmental supply of {subj}? | C0224268 | Structure of extensor digitorum muscle of hand | C1305861 | C7 innervation | C7 level | C7 innervation | C3 branch to splenius cervicis | C3 branch to left trapezius | 1 |
C0224364::has_segmental_supply | has_segmental_supply | What is the segmental supply of {subj}? | C0224364 | Structure of rhomboid minor muscle | C1305859 | C5 innervation | C3 branch to splenius cervicis | C3 branch to multifidus | C5 innervation | C1 branch to left splenius capitis | 2 |
C0373665::has_specialty | has_specialty | Which specialty is associated with {subj}? | C0373665 | Lactose, urine, qualitative | C1551301 | Clinical Medical Laboratory | Expert Systems | Hospital-based outpatient department | Hospitals | Clinical Medical Laboratory | 3 |
C3203353::has_specialty | has_specialty | Which specialty is associated with {subj}? | C3203353 | Measurement of fibrinogen antigen | C1551301 | Clinical Medical Laboratory | Clinical Medical Laboratory | Clinical Observation Units | Rural Health Center | Residential institution | 0 |
C4521017::has_specialty | has_specialty | Which specialty is associated with {subj}? | C4521017 | Serum Immunofixation Electrophoresis | C1551301 | Clinical Medical Laboratory | Hospitals | Physical medicine and rehabilitation service | Medical intensive care unit | Clinical Medical Laboratory | 3 |
C0587025::has_specimen_source_topography | has_specimen_source_topography | What is the specimen source topography of {subj}? | C0587025 | Hysterectomy and unilateral salpingo-oophorectomy sample | C0042149 | Uterus | Uterus NEC | Left uterine artery | Uterus | Left horn of uterus | 2 |
C1292684::has_specimen_source_topography | has_specimen_source_topography | What is the specimen source topography of {subj}? | C1292684 | Specimen from urethra | C0041967 | Urethra | Prostatic Urethra | Urethra | Urethral vein | Urethralis muscle | 1 |
C0586648::has_specimen_source_topography | has_specimen_source_topography | What is the specimen source topography of {subj}? | C0586648 | Pleura biopsy specimen | C0032225 | Pleura | Left pleural mesothelium | Pleura | Epineurium | Bursa specimen | 1 |
C2725899::has_structural_class | has_structural_class | What structural class does {subj} belong to? | C2725899 | white catfish allergenic extract | C0002092 | Allergens | Drug specific allergen extract | Allergens | Allergen extract vaccine | Occupational allergens | 1 |
C0006837::has_structural_class | has_structural_class | What structural class does {subj} belong to? | C0006837 | Candida albicans | C0002092 | Allergens | Allergens | Deer allergen | Occupational allergens | Drug specific allergen extract | 0 |
C4519831::has_structural_class | has_structural_class | What structural class does {subj} belong to? | C4519831 | Parathyroid Hormone-Related Peptide Analog | C0070099 | parathyroid hormone-related protein | estrogen receptor beta, human | parathyroid hormone-related protein | transferrin receptor 2, human | Tyrosinase related protein-1 | 1 |
C2697532::has_target | has_target | What is the target of {subj}? | C2697532 | HDAC/EGFR/HER2 Inhibitor CUDC-101 | C1702024 | ERBB2 protein, human | GABBR2 protein, human | ERBB2 protein, human | FCGR2B protein, human | NCAM2 protein, human | 1 |
C5784712::has_target | has_target | What is the target of {subj}? | C5784712 | Anti-CLDN18.2 Monoclonal Antibody ZL-1211 | C4725710 | Claudin-18 Isoform A2 | Tropomyosin Alpha-3 Chain Isoform 3, human | Anti-PD-L1/Claudin18.2 Bispecific Antibody Q-1802 | Anti-claudin18.2 Monoclonal Antibody AB011 | Claudin-18 Isoform A2 | 3 |
C5783547::has_target | has_target | What is the target of {subj}? | C5783547 | Anti-BTN1A1 Monoclonal Antibody hSTC810 | C4308231 | BTN1A1 protein, human | NTNG1 protein, human | STMN1 protein, human | BTN1A1 protein, human | ACTN1 protein, human | 2 |
C5852778::has_technique | has_technique | What technique is used for {subj}? | C5852778 | Percent of cell nuclei positive for proliferation marker protein Ki-67 in primary malignant neoplasm of cecum and/or colon and/or rectum by immunohistochemistry | C0021044 | Immunohistochemistry | Microscopic Angioscopy | Specular microscopy | indirect immunofluorescent study of IgA antibody | Immunohistochemistry | 3 |
C5852777::has_technique | has_technique | What technique is used for {subj}? | C5852777 | Number of tumor buds in primary malignant neoplasm of cecum and/or colon and/or rectum in microscopic field 0.785 square millimeter | C0430389 | Light Microscopy | Light Microscopy | Immunoelectron microscopy study | Low power light microscopy | hairy cells by light microscopy | 0 |
C5818634::has_technique | has_technique | What technique is used for {subj}? | C5818634 | Differential count of white blood cells by manual method | C1441639 | Manual count | Listeria culture | Lead measurement | Boron measurement | Manual count | 3 |
C2351042::has_therapeutic_class | has_therapeutic_class | Which therapeutic class does {subj} belong to? | C2351042 | besifloxacin | C4722060 | Ophthalmic Agents [TC] | Cortisporin Ophthalmic | tropicamide ophthalmic compounding powder | Ophthalmic Agents [TC] | Antimalarial [EPC] | 2 |
C0771341::has_therapeutic_class | has_therapeutic_class | Which therapeutic class does {subj} belong to? | C0771341 | cefpirome sulfate | C0279516 | Anti-Bacterial Agents | Macrolide Antibiotics | gentamicin compounding powder | Gramicidin- and neomycin-containing product | Anti-Bacterial Agents | 3 |
C1434792::has_therapeutic_class | has_therapeutic_class | Which therapeutic class does {subj} belong to? | C1434792 | ibalizumab | C0003451 | Antiviral Agents | Tocolytic Agents | Antiplatelet Agents | Aviral | Antiviral Agents | 3 |
C0030092::has_tradename | has_tradename | What is a trade name for {subj}? | C0030092 | oxytetracycline | C0723652 | Terramycin with Polymyxin B Sulfate | Polymyxin b sulfate 100% powder | Polymyxin-class Antibacterial [EPC] | Neomycin Sulfate/ Fluocinolone Acetonide | Terramycin with Polymyxin B Sulfate | 3 |
C0002371::has_tradename | has_tradename | What is a trade name for {subj}? | C0002371 | aluminum hydroxide | C0591749 | Maalox Plus | Foltabs 90 Plus DHA | Sobrerol only product | Denufosol only product | Maalox Plus | 3 |
C0001143::has_tradename | has_tradename | What is a trade name for {subj}? | C0001143 | aclarubicin | C1515872 | Aclacinon | Lotrimin AF | Brometane DX | pafolacianine sodium | Aclacinon | 3 |
C0501289::has_tributary | has_tributary | Which of the following is a tributary of {subj}? | C0501289 | Left subcostal vein | C0504899 | Structure of anterior external vertebral venous plexus | Structure of anterior vertebral vein | Structure of anterior external vertebral venous plexus | Entire venous plexus of the hypoglossal canal | Structure of uterine venous plexus | 1 |
C0004456::has_tributary | has_tributary | Which of the following is a tributary of {subj}? | C0004456 | Structure of axillary vein | C0226801 | Structure of basilic vein | Structure of glabella | Structure of tarsal muscle | Structure of pontine artery | Structure of basilic vein | 3 |
C0505055::has_tributary | has_tributary | Which of the following is a tributary of {subj}? | C0505055 | Left eleventh posterior thoracic radicular vein | C0501297 | Medullary tributary of left eleventh posterior intercostal vein | Prelaminar branch of left fourth posterior intercostal artery | Medullary tributary of left eleventh posterior intercostal vein | Postcentral branch of left second posterior intercostal artery | Postcentral branch of left fourth posterior intercostal artery | 1 |
C1458155::human_disease_maps_to_eo_disease | human_disease_maps_to_eo_disease | Which experimental organism disease does the human disease {subj} map to? | C1458155 | Mammary Neoplasms | C1517920 | LobuloAlveolar Mouse MIN | LobuloAlveolar Mouse MIN | Lethal midline granuloma stage IV | BAP1-inactivated melanocytoma | Posterior Fossa Ependymoma, Group B (PFB) | 0 |
C0018671::human_disease_maps_to_eo_disease | human_disease_maps_to_eo_disease | Which experimental organism disease does the human disease {subj} map to? | C0018671 | Head and Neck Neoplasms | C1514150 | Plasmacytoma of the Mouse Pharynx | Plasmacytoma of the Mouse Pharynx | Extramedullary Plasmacytoma | Testicular Plasmacytoma | Anaplastic Pleomorphic Xanthoastrocytoma | 0 |
C0017416::human_disease_maps_to_eo_disease | human_disease_maps_to_eo_disease | Which experimental organism disease does the human disease {subj} map to? | C0017416 | Genital Neoplasms, Female | C1522317 | Mouse Cervical Carcinoma | Cervical Squamous Cell Carcinoma | Mouse Cervical Carcinoma | Cervical Serous Adenocarcinoma | Metastatic Cervical Carcinoma | 1 |
C0079829::ingredient_of | ingredient_of | Which of the following contains {subj} as an ingredient? | C0079829 | methacholine chloride | C0703919 | methacholine 100 mg inhalation powder for reconstitution | methacholine 100 mg inhalation powder for reconstitution | Urea[13C] 100mg powder for oral solution | Dextrose Monohydrate 0.245 g in 10 mL / Sodium Citrate, Unspecified Form 0.220 g in 10 mL / Citric Acid Monohydrate 0.08 g in 10 mL INTRAVENOUS SOLUTION [Anticoagulant Citrate Dextrose (ACD-A)] | perflubutane, phospholipid microspheres | 0 |
C0949359::ingredient_of | ingredient_of | Which of the following contains {subj} as an ingredient? | C0949359 | methotrexate sodium | C2242198 | {16 (methotrexate 2.5 MG Oral Tablet) } Pack | {60 (doxycycline monohydrate 100 MG Oral Tablet) } Pack | {5 (levofloxacin 750 MG Oral Tablet) } Pack | {16 (methotrexate 2.5 MG Oral Tablet) } Pack | {28 (everolimus 5 MG Oral Tablet) } Pack | 2 |
C0717762::ingredient_of | ingredient_of | Which of the following contains {subj} as an ingredient? | C0717762 | Ethinyl Estradiol / norgestimate | C1877749 | {21 (ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack | {21 (ethinyl estradiol 0.035 MG / norethindrone 0.4 MG Chewable Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack | {21 (ethinyl estradiol 0.035 MG / norethindrone 0.4 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Rhuzdah 28 Day] | {21 (ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack | {21 (ethinyl estradiol 0.02 MG / levonorgestrel 0.1 MG Chewable Tablet) / 7 (inert ingredients 1 MG Chewable Tablet) } Pack | 2 |
C0031354::inherent_location_of | inherent_location_of | For which of the following is {subj} the inherent location? | C0031354 | Pharyngeal structure | C5852806 | Relative location of involved lymph nodes to primary malignant neoplasm of pharynx | Visceral pleura involved by direct extension of malignant neoplasm | Relative location of involved lymph nodes to primary malignant neoplasm of pharynx | Macroscopic anatomic location of primary malignant neoplasm | Number of lymph nodes containing isolated metastatic neoplastic cells in excised specimen | 1 |
C5848823::inherent_location_of | inherent_location_of | For which of the following is {subj} the inherent location? | C5848823 | Structure of cecum and/or colon and/or rectum | C5852777 | Number of tumor buds in primary malignant neoplasm of cecum and/or colon and/or rectum in microscopic field 0.785 square millimeter | Presence of macroscopic perforation of small intestine by primary malignant neoplasm of small intestine | Number of tumor buds in primary malignant neoplasm of cecum and/or colon and/or rectum in microscopic field 0.785 square millimeter | Neoplasm of colon regional lymph node staging category N1c: Tumor deposit(s) in subserosa, mesentery, or nonperitonealized pericolic or perirectal tissues without regional nodal metastasis | Number of lymph nodes of para-aortic lymph node group containing isolated metastatic neoplastic cells in excised specimen | 1 |
C0027763::inherent_location_of | inherent_location_of | For which of the following is {subj} the inherent location? | C0027763 | Nervous system structure | C0036658 | Sensory perception | Sensory perception | Melanin pigmentation | Nociception | detection of mechanical stimulus involved in sensory perception of touch | 0 |
C0441748::inheritance_type_of | inheritance_type_of | For which genetic condition is {subj} the inheritance type? | C0441748 | Autosomal recessive inheritance | C1832800 | Micromelic dwarfism Fryns type | Micromelic dwarfism Fryns type | Microcephalic primordial dwarfism Dauber type | Macrodactyly of fingers - simple | Median nail dystrophy of Heller | 0 |
C0443147::inheritance_type_of | inheritance_type_of | For which genetic condition is {subj} the inheritance type? | C0443147 | Autosomal dominant inheritance | C1835007 | Metachromatic Leukodystrophy, Adult-Onset, with Normal Arylsulfatase A | Ectodermal Dysplasia, Hypohidrotic, with Hypothyroidism and Ciliary Dyskinesia | Dystonia, Dopa-Responsive, With Or Without Hyperphenylalaninemia, Autosomal Recessive | Metachromatic Leukodystrophy, Adult-Onset, with Normal Arylsulfatase A | Dyskinesia, Familial, with Facial Myokymia | 2 |
C0241764::inheritance_type_of | inheritance_type_of | For which genetic condition is {subj} the inheritance type? | C0241764 | X-linked inheritance | C4310811 | MEESTER-LOEYS SYNDROME | MEESTER-LOEYS SYNDROME | BECK-FAHRNER SYNDROME, AUTOSOMAL DOMINANT | EHLERS-DANLOS SYNDROME, NONVASCULAR VARIANT | STUVE-WIEDEMANN SYNDROME | 0 |
C0199176::intent_of | intent_of | For which procedure is {subj} the intent? | C0199176 | Prophylactic treatment | C3532848 | Administration of prophylactic antiviral after potential sexual exposure to human immunodeficiency virus | Administration of second dose of pediatric hepatitis A vaccine | Japanese encephalitis virus vaccine, inactivated, for intramuscular use | Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered | Administration of prophylactic antiviral after potential sexual exposure to human immunodeficiency virus | 3 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.